RT Journal Article
SR Electronic
T1 Epidemiological health assessment in primary health care in the State of Qatar-2019
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.02.27.21251797
DO 10.1101/2021.02.27.21251797
A1 Mohamed Ghaith Al-Kuwari
A1 Samya Ahmad Al – Abdulla
A1 Maha Yousef Abdulla
A1 Ahmad Haj Bakri
A1 Azza Mustafa Mohammed
A1 Mujeeb Chettiyam Kandy
A1 Amanda Patterson
YR 2021
UL http://medrxiv.org/content/early/2021/03/02/2021.02.27.21251797.abstract
AB Objectives The Primary Health Care Corporation (PHCC) in Qatar conducted epidemiological health assessment to understand the burden of diseases impacting the PHCC registered populationDesign This is a cross-sectional study design among all PHCC registered population between the 1st of September 2018 and the 31st of August 2019Setting Primary Health Care Corporation health centersParticipants The target population is all persons residing in Qatar aged (0-80) years and registered at the PHCC. Excluding patients with expired Qatar residence permit by the 31st of AugustResults Obesity rates ranged between 37% and 35% among the total population registered with the lowest rate in the central region at 34.7%. Burden of type 2 diabetes, hypertension, and dyslipidemia was the highest among population of the Central region at 13.9%, 15.7% and 11.1%, respectively. Tobacco consumption among males ranged from 25.4 % to 27.8%, with the highest rate in the Northern region. 39.9% of females in the Northern region had BMI above 30 kg/m2. Exclusive breastfeeding at 6 months was significantly lower than that at 4 months across all regions. Children in the Northern region had the highest rate of overweight/obesity based on Z-scores. Western region population had the highest number of communicable diseases notifications especially Chicken pox at 94.6 per 10,000 childrenConclusion Understanding the patterns of disease in the local population will enable PHCC to provide a clear set of objectives to work towards meeting population health needsCompeting Interest StatementThe authors have declared no competing interest.Funding StatementNo funding was required.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The epidemiological health assessment was approved by the PHCC Corporate Strategy Implementation group at PHCC in April 2019. The project was exempt from IRB approval as data was extracted retrospectively as part of epidemiological activities to support better development of the PHCC key strategic activities for better service provision towards its target population. The project was presented later at the PHCC scientific research committee representing the PHCC IRB committee in which it approved the study and provided the required ethical approval for conducting this studyAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data is available upone request.